Vaccine breakthrough stops cancer returning in trial
A new personalised vaccine given in combination with a drug has stopped skin cancer returning in patients during a trial, ***representing a potentially watershed moment in cancer treatment***.
The **phase three trial involved more than 1,000 patients who had high-risk stage two, three or four melanoma** \- meaning they ranged from having large tumours in a specific area to cancers which had already spread to other parts of the body. #news #inspiration